ES2032681T3 - Una composicion farmaceutica anti-inflamatoria, con eliminacion, en solucion, de sabor amargo, ardor de la garganta y toxicidad intestinal. (reserva del art. 167.2 cpe). - Google Patents

Una composicion farmaceutica anti-inflamatoria, con eliminacion, en solucion, de sabor amargo, ardor de la garganta y toxicidad intestinal. (reserva del art. 167.2 cpe).

Info

Publication number
ES2032681T3
ES2032681T3 ES198989810376T ES89810376T ES2032681T3 ES 2032681 T3 ES2032681 T3 ES 2032681T3 ES 198989810376 T ES198989810376 T ES 198989810376T ES 89810376 T ES89810376 T ES 89810376T ES 2032681 T3 ES2032681 T3 ES 2032681T3
Authority
ES
Spain
Prior art keywords
throat
elimination
burning
bitter taste
cpe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989810376T
Other languages
English (en)
Inventor
Mario Carcano
Massimo Costa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpex Pharma SA
Original Assignee
Aesculapius Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4238447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2032681(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aesculapius Pharma SA filed Critical Aesculapius Pharma SA
Application granted granted Critical
Publication of ES2032681T3 publication Critical patent/ES2032681T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL PROCEDIMIENTO HACE POSIBLE LA PREPARACION DE AGENTES FARMACEUTICOS ANTIINFLAMATORIOS CON UNA BASE DE IBUPROFEN, CON ELIMINACION DEL SABOR AMARGO, DEL ARDOR EN LA GARGANTA Y DE LA TOXICIDAD TOPICA AL NIVEL DE LA PARED INTESTINAL, CUANDO SE TOMAN SUS DISOLUCIONES ACUOSAS EFERVESCENTES. LAS PROPORCIONES ENTRE LOS INGREDIENTES PRINCIPALES DE CADA AGENTE FARMACEUTICO SON LAS SIGUIENTES: IBUPROFEN, 200-800 MG; SAL SODICA DE IBUPROFEN, 221,3-885,2 MG; BICARBONATO SODICO, 2,100-8,402 G; ACIDO CITRICO, 0,450-1,800 G. TAMBIEN SEPROTEGEN LOS AGENTES FARMACEUTICOS PREPARADOS CON EL PROCESO, EN ESPECIAL LAS PASTILLAS Y GRANULOS EFERVESCENTES.
ES198989810376T 1988-07-12 1989-05-22 Una composicion farmaceutica anti-inflamatoria, con eliminacion, en solucion, de sabor amargo, ardor de la garganta y toxicidad intestinal. (reserva del art. 167.2 cpe). Expired - Lifetime ES2032681T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2647/88A CH677606A5 (es) 1988-07-12 1988-07-12

Publications (1)

Publication Number Publication Date
ES2032681T3 true ES2032681T3 (es) 1993-02-16

Family

ID=4238447

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989810376T Expired - Lifetime ES2032681T3 (es) 1988-07-12 1989-05-22 Una composicion farmaceutica anti-inflamatoria, con eliminacion, en solucion, de sabor amargo, ardor de la garganta y toxicidad intestinal. (reserva del art. 167.2 cpe).

Country Status (11)

Country Link
US (1) US5180590A (es)
EP (1) EP0351353B1 (es)
JP (1) JPH07112973B2 (es)
AT (1) ATE73656T1 (es)
CA (1) CA1336323C (es)
CH (1) CH677606A5 (es)
DE (1) DE68901014D1 (es)
DK (1) DK342989A (es)
ES (1) ES2032681T3 (es)
GR (1) GR3004148T3 (es)
ZA (1) ZA894828B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
ES2148175T3 (es) 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
EP0667149A1 (en) * 1994-02-14 1995-08-16 E-PHARMA TRENTO S.p.A. Ibuprofen based effervescent composition
GB9426196D0 (en) * 1994-12-23 1995-02-22 Procter & Gamble Processes of preparing pharmaceutical compositions
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
WO1997004754A1 (de) * 1995-07-31 1997-02-13 Gerhard Gergely Kautablette mit brausewirkung
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
NZ333474A (en) 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US20050176599A1 (en) * 2000-11-09 2005-08-11 Bergquist Catharine J. Controlled delivery system for household products
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
PT1804772E (pt) * 2004-08-12 2011-12-02 Reckitt Benckiser Healthcare Grânulos que compreendem um fármaco anti-inflamatório não esteróide e um álcool de açúcar feito por extrusão de fundido
WO2007055887A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EP1905428A1 (de) * 2006-09-26 2008-04-02 Losan Pharma GmbH Ibuprofen-Brausezubereitung mit hoher Lösungsgeschwindigkeit und Verfahren zu deren Herstellung
TR200900881A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
EP2704696A1 (en) 2012-03-26 2014-03-12 Glatt AG Taste-masked ibuprofen granules
ES2612238T3 (es) 2014-02-27 2017-05-12 Galenicum Health S.L. Composiciones farmacéuticas estables
EP3157506B1 (en) * 2014-06-20 2020-08-26 Hermes Arzneimittel GmbH Taste-masked oral pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations

Also Published As

Publication number Publication date
DE68901014D1 (de) 1992-04-23
US5180590A (en) 1993-01-19
CA1336323C (en) 1995-07-18
GR3004148T3 (es) 1993-03-31
EP0351353B1 (en) 1992-03-18
CH677606A5 (es) 1991-06-14
ATE73656T1 (de) 1992-04-15
JPH0272115A (ja) 1990-03-12
EP0351353A1 (en) 1990-01-17
JPH07112973B2 (ja) 1995-12-06
DK342989D0 (da) 1989-07-11
ZA894828B (en) 1990-03-28
DK342989A (da) 1990-01-13

Similar Documents

Publication Publication Date Title
ES2032681T3 (es) Una composicion farmaceutica anti-inflamatoria, con eliminacion, en solucion, de sabor amargo, ardor de la garganta y toxicidad intestinal. (reserva del art. 167.2 cpe).
RU2009105770A (ru) Сухая композиция для смешивания с водой (варианты), очистительный препарат и набор компонентов для очистки толстой кишки и способ очищения толстой кишки (варианты)
SE8702940D0 (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
KR910000100A (ko) 라니티딘 함유 제약 조성물
EP0566638A1 (en) Flavor stable zinc acetate compositions for oral absorption
US5538959A (en) Analgesic composition for treatment of migraine headaches
CA2050970A1 (en) Pharmaceutical compositions containing furan derivatives
CA2464151A1 (en) Ribavirin syrup formulations
EP0719148B1 (en) Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
IE791995L (en) Formulation
GR3002835T3 (en) Pharmaceutical compositions containing pentamidine
CA2081408A1 (en) Composition for the cleaning of teeth and the prophylaxis of caries
JPS5661311A (en) Thial amide or prolonged pharmaceutical preparation comprising its salt
JPS56138110A (en) Suppository containing citric acid or salt thereof
ATE242626T1 (de) Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält
GB1475861A (en) Pharmaceutical composition
JPS61280419A (ja) 治療用錠剤状製剤
RU2276982C2 (ru) Средство, обладающее противовоспалительным, анальгетическим, жаропонижающим действием в форме таблетки
RU93019551A (ru) Антибактериальный противовоспалительный препарат
JPS57144214A (en) Pharmaceutical preparation for rectum medication
JPS57158719A (en) Rectal administration pharmaceutical
ES8303915A1 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
AU3772697A (en) Pharmaceutical composition to be administered orally
DE68901852T2 (de) Primycin-loesungen.